Your browser doesn't support javascript.
loading
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Peyrin-Biroulet, Laurent; Arkkila, Perttu; Armuzzi, Alessandro; Danese, Silvio; Guardiola, Jordi; Jahnsen, Jørgen; Lees, Charles; Louis, Edouard; Lukás, Milan; Reinisch, Walter; Roblin, Xavier; Jang, Minyoung; Byun, Han Geul; Kim, Dong-Hyeon; Lee, Sung Jeong; Atreya, Raja.
Affiliation
  • Peyrin-Biroulet L; Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
  • Arkkila P; Department of Gastroenterology, Helsinki University and Helsinki University Hospital, Helsinki, Finland.
  • Armuzzi A; Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Danese S; Gastroenterology and Endoscopy, University Vita-Salute San Raffaele, Milan, Italy.
  • Guardiola J; Digestive Diseases Department, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Jahnsen J; Department of Gastroenterology, Institute of Clinical Medicine, Akershus University Hospital, University of Oslo, Oslo, Norway.
  • Lees C; Center of Genomics and Experimental Medicine, University of Edinburgh, Edinburgh, UK.
  • Louis E; Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium.
  • Lukás M; ISCARE Clinical Centre, Prague, Czech Republic.
  • Reinisch W; Medical University of Vienna, Vienna, Austria.
  • Roblin X; University Hospital of Saint-Etienne, Saint-Etienne, France.
  • Jang M; Celltrion Healthcare, Incheon, Republic of Korea.
  • Byun HG; Celltrion Healthcare, Incheon, Republic of Korea.
  • Kim DH; Celltrion Healthcare, Incheon, Republic of Korea.
  • Lee SJ; Celltrion Healthcare, Incheon, Republic of Korea.
  • Atreya R; Medical Department 1, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany. raja.atreya@uk-erlangen.de.
BMC Gastroenterol ; 22(1): 291, 2022 Jun 08.
Article in En | MEDLINE | ID: mdl-35676620

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: Francia